Position in EPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$547,706
-$36,664 QoQ
Shares Held
75,650
-2.3% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 54 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INGALLS & SNYDER LLC holds $352,579,823 across 11 Biotechnology names. EPRX ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
7,608,716 | $306,707,341 | |
| 2 | OMER |
Omeros Corp
|
3,559,423 | $37,587,506 | |
| 3 | HYFT |
MindWalk Holdings Corp.
|
2,907,040 | $3,284,955 | |
| 4 | GMAB |
Genmab A/S
|
72,891 | $1,955,665 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,012 | $1,344,978 | |
| 6 | EPRX |
Eupraxia Pharmaceuticals Inc.
This page
|
75,650 | $547,706 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
7,339 | $474,319 | |
| 8 | VCEL |
Vericel Corp
|
14,200 | $456,814 |
All Filings in EPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $547,706 | 75,650 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $584,370 | 77,400 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $348,690 | 59,100 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $214,272 | 37,200 | Shares | Other | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||